Found: 10
Select item for more details and to access through your institution.
CYP3A4 and MDR1 Alleles in a Portuguese Population.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2003, v. 41, n. 10, p. 1345, doi. 10.1515/CCLM.2003.206
- By:
- Publication type:
- Article
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.
- Published in:
- Biopharmaceutics & Drug Disposition, 2012, v. 33, n. 2, p. 99, doi. 10.1002/bdd.1771
- By:
- Publication type:
- Article
Artificial Intelligence and Machine Learning Applied at the Point of Care.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00759
- By:
- Publication type:
- Article
Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 563, doi. 10.1002/cpt.3289
- By:
- Publication type:
- Article
An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1168, doi. 10.1002/cpt.2243
- By:
- Publication type:
- Article
A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 9, p. 967, doi. 10.1002/psp4.12678
- By:
- Publication type:
- Article
Regulatory aspects of pharmacokinetic profiling in special populations: a European perspective.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Regulatory Aspects of Pharmacokinetic Profiling in Special Populations.
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 11, p. 693, doi. 10.2165/00003088-200847110-00001
- By:
- Publication type:
- Article
Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, p. 91S, doi. 10.1177/0091270011415528
- By:
- Publication type:
- Article
Inhibitors of Organic Anion‐Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 8, p. 1087, doi. 10.1002/jcph.1604
- By:
- Publication type:
- Article